Skip to Content

N 741 250 (Mexiletine 250 mg)

Pill imprint N 741 250 has been identified as Mexiletine hydrochloride 250 mg.

Mexiletine is used in the treatment of diabetic peripheral neuropathy; ventricular tachycardia; myotonia congenita; arrhythmia and belongs to the drug class group I antiarrhythmics. Risk cannot be ruled out during pregnancy. Mexiletine 250 mg is not a controlled substance under the Controlled Substance Act (CSA).

Mexiletine hydrochloride 250 mg N 741 250
Mexiletine hydrochloride 250 mg N 741 250
Mexiletine hydrochloride 250 mg N 741 250
Mexiletine hydrochloride
N 741 250
250 mg
Green & Orange
Prescription only
Drug Class:
Group I antiarrhythmics
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Teva Pharmaceuticals USA
National Drug Code (NDC):
Inactive Ingredients:
silicon dioxide
magnesium stearate
corn starch
FD&C Yellow No. 6
titanium dioxide
D&C Yellow No. 10
FD&C Blue No. 1
ferrosoferric oxide
FD&C Blue No. 2
FD&C Red No. 40
isopropyl alcohol
butyl alcohol
propylene glycol
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
42291-0626 AvKare, Inc.
55045-3635 Dispensing Solutions Inc. (repackager)
49999-0917 Lake Erie Medical and Surgical Supply (repackager)

Note: Inactive ingredients may vary.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.